Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)

BACKGROUND: We conducted an economic assessment using test data from the phase III TRIPLE study, which examined the efficacy of a 5-hydroxytryptamine 3 receptor antagonist as part of a standard triplet antiemetic regimen including aprepitant and dexamethasone in preventing chemotherapy-induced nause...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Hisanori, Suzuki, Kenichi, Uchikura, Takeshi, Tsuji, Daiki, Yamanaka, Takeharu, Hashimoto, Hironobu, Goto, Koichi, Matsui, Reiko, Seki, Nobuhiko, Shimada, Toshikazu, Ikeda, Shunya, Ikegami, Naoki, Hama, Toshihiro, Yamamoto, Nobuyuki, Sasaki, Tadanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287343/
https://www.ncbi.nlm.nih.gov/pubmed/30555710
http://dx.doi.org/10.1186/s40780-018-0128-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287343/
https://www.ncbi.nlm.nih.gov/pubmed/30555710
http://dx.doi.org/10.1186/s40780-018-0128-9

Ejemplares similares